Murphy L C, Dotzlaw H, Leygue E, Douglas D, Coutts A, Watson P H
Department of Biochemistry and Molecular Biology, University of Manitoba, Winnipeg, Canada.
J Steroid Biochem Mol Biol. 1997 Aug;62(5-6):363-72. doi: 10.1016/s0960-0760(97)00084-8.
There is a large and increasing body of experimental and clinical data supporting the existence or variant estrogen receptor (ER) proteins in both normal and neoplastic estrogen target tissues including human breast. Therefore, future examination of ER signal transduction and/or measurement of ER protein must take into account variant ER expression. The functions of variant ER proteins, either physiological or pathological, remain unclear, although a role(s) for some ER variants in breast tumorigenesis and breast cancer progression would be consistent with the accumulated data. Possible tissue specific expression leads to the speculation that ER variants may have a role in tissue specific estrogen action. The following review focuses on the current knowledge available in the scientific literature with respect to the type and characteristics of estrogen receptor variants and mutations that have been identified to occur naturally in tissues and cell lines.
有大量且不断增加的实验和临床数据支持在包括人类乳腺在内的正常和肿瘤性雌激素靶组织中存在变异雌激素受体(ER)蛋白。因此,未来对ER信号转导的研究和/或ER蛋白的测量必须考虑变异ER的表达。尽管一些ER变异体在乳腺肿瘤发生和乳腺癌进展中的作用与积累的数据一致,但其生理或病理功能仍不清楚。可能的组织特异性表达引发了这样的推测,即ER变异体可能在组织特异性雌激素作用中发挥作用。以下综述聚焦于科学文献中关于已确定在组织和细胞系中自然发生的雌激素受体变异体和突变的类型及特征的现有知识。